MTF2: A Potential Drug Target for Various Diseases (G22823)

Target Name: MTF2

NCBI ID: G22823

MTF2

MTF2: A Potential Drug Target for Various Diseases

MTF2 (MTF2 variant 1) is a protein that is expressed in a variety of tissues throughout the body, including the brain, heart, and kidneys. It is a key regulator of cell division and growth, and is involved in many important cellular processes that are necessary for human health and development.

Recent studies have identified MTF2 as a potential drug target for a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders. This is because MTF2 has been shown to play a role in the development and progression of these conditions, and in many cases,MTF2 inhibition has been shown to have therapeutic benefits.

One of the key reasons for the potential of MTF2 as a drug target is its involvement in the regulation of cell division and growth. MTF2 is a critical regulator of the G1/S transition, which is the stage of cell division where the cell prepares for growth and division. During the G1/S transition, MTF2 plays a role in the inhibition of cell cycle progression to the S phase, which is the stage of cell growth and division where the cell divides.

This involvement in cell division and growth makes MTF2 a potentially attractive target for drugs that are designed to inhibit cell proliferation. In fact, several studies have shown that MTF2 inhibitors have been effective in preclinical models of cancer, including inhibiting the growth of breast cancer cells and the spread of cancer to other tissues.

Another potential mechanism by which MTF2 may be targeted by drugs is its role in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. These conditions are characterized by the progressive loss of brain cells, and are often associated with increased levels of certain proteins, including MTF2.

Studies have shown that MTF2 is involved in the regulation of neurotransmitter release from neurons, which is important for the function of the brain. Additionally, MTF2 has been shown to play a role in the regulation of axon growth and differentiation, which is important for the development and maintenance of neural circuits.

In addition to its role in neurodegenerative diseases, MTF2 has also been shown to be involved in the development and progression of other conditions, including developmental disorders and cancer. For example, MTF2 has been shown to play a role in the development of neurofibromatosis, a condition characterized by the progressive growth of nerve fibers.

In conclusion, MTF2 is a protein that has been shown to be involved in a variety of cellular processes that are important for human health and development. As a result, MTF2 has emerged as a potentially promising drug target for a variety of conditions, including cancer, neurodegenerative diseases, and developmental disorders. Further research is needed to fully understand the role of MTF2 in these conditions, and to develop effective therapies that take advantage of this promising target.

Protein Name: Metal Response Element Binding Transcription Factor 2

Functions: Polycomb group (PcG) protein that specifically binds histone H3 trimethylated at 'Lys-36' (H3K36me3) and recruits the PRC2 complex, thus enhancing PRC2 H3K27me3 methylation activity (PubMed:23142980, PubMed:23228662, PubMed:31959557). Regulates the transcriptional networks during embryonic stem cell self-renewal and differentiation (By similarity). Promotes recruitment of the PRC2 complex to the inactive X chromosome in differentiating XX ES cells and PRC2 recruitment to target genes in undifferentiated ES cells (By similarity). Required to repress Hox genes by enhancing H3K27me3 methylation of the PRC2 complex (By similarity). In some conditions may act as an inhibitor of PRC2 activity: able to activate the CDKN2A gene and promote cellular senescence by suppressing the catalytic activity of the PRC2 complex locally (By similarity). Binds to the metal-regulating-element (MRE) of MT1A gene promoter (By similarity)

The "MTF2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTF2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets